Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer
Myeloid-derived suppressor cells in glioma
Dendritic cell-based immunotherapy in ovarian cancer
Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
[Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer]
Dendritic cell vaccine for recurrent high-grade gliomas in pediatric and adult subjects: clinical trial protocol
[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer]
Dendritic cells, inflammation, and breast cancer
Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study
Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials
Exploiting dendritic cells in the development of cancer vaccines
A review of dendritic cell therapy for cancer: progress and challenges
Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials
Temperature matters! And why it should matter to tumor immunologists
Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes
Oncolytic viruses as therapeutic cancer vaccines
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma
Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer